Composition for treating inflammatory bowel disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/355 (2006.01)

Patent

CA 2539025

A method for reducing inflammation in inflammatory bowel disease is disclosed. The method comprises reducing the expression of endothelial cell adhesion molecules in the vasculature of the bowel wall by administering a therapeutic dosage of an effective amount of a blend of vitamin E TPGS and gamma- tocopherol. Gamma-tocopherol is also useful when used alone in the invention. The reduction in endothelial cell adhesion molecules is due to the deactivation of endothelial NFK-B by the composition.

L'invention concerne une méthode de réduction de l'inflammation dans la maladie intestinale inflammatoire. Ladite méthode consiste à réduire l'expression des molécules d'adhésion des cellules endothéliales dans le système vasculaire de la paroi intestinale par administration d'une dose thérapeutique d'une quantité efficace d'un mélange de vitamine E TPGS et de gamma tocophérol. Le gamma tocophérol est également utilisé seul dans l'invention. La réduction des molécules d'adhésion des cellules endothéliales est due à la désactivation du NF<SB>K</SB>-B endothélial par la composition.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for treating inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for treating inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating inflammatory bowel disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1451403

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.